<PAGE> 1
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
PURSUANT TO SECTION 14(D)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)
------------------------------
DEKALB GENETICS CORPORATION
(Name of Subject Company)
DEKALB GENETICS CORPORATION
(Name of Person(s) Filing Statement)
CLASS B COMMON STOCK, WITHOUT PAR VALUE
(Title of Class of Securities)
244878 20 3
(CUSIP Number of Class of Securities)
John H. Witmer, Jr., Esq.
Senior Vice President and General Counsel
3100 Sycamore Road
DeKalb, Illinois 60115
(815) 758-3461
(Name, address and telephone number of person
authorized to receive notice and communications
on behalf of the person(s) filing statement)
------------------------------
COPIES TO:
James G. Archer Peter D. Lyons
Sidley & Austin Shearman & Sterling
875 Third Avenue 599 Lexington Avenue
New York, NY 10022 New York, NY 10022
(212) 906-2000 (212) 848-4000
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
This Amendment No. 2 amends and supplements the Solicitation/Recommendation
Statement on Schedule 14D-9 filed with the Securities and Exchange Commission on
February 7, 1996 (as amended, the "Schedule 14D-9") by DEKALB Genetics
Corporation, a Delaware corporation (the "Company"), relating to the tender
offer by Monsanto Company, a Delaware corporation ("Monsanto"), to purchase up
to 1,800,000 shares of the Class B Common Stock, without par value, of the
Company ("Class B Stock"), at a price per share of $71.00, net to the seller in
cash, upon the terms and subject to the conditions set forth in the Offer to
Purchase of Monsanto dated February 7, 1996 and in the related Letter of
Transmittal (which collectively constitute the "Offer"), which are attached as
Exhibits (a)(1) and (a)(2), respectively, to the Tender Offer Statement on
Schedule 14D-1 filed by Monsanto. The Offer expired at 12:00 midnight, New York
City time, on March 6, 1996. Unless otherwise defined herein, all capitalized
terms used herein shall have the meanings set forth in the Schedule 14D-9.
ITEM 2. TENDER OFFER OF THE BIDDER
On March 7, 1996, Monsanto consummated the Offer by accepting for payment
1,723,738 shares of Class B Stock, subject in the case of 72,713 shares of Class
B Stock tendered pursuant to notices of guaranteed delivery to the physical
receipt of certificates therefor. Such shares accepted for payment constituted
all of the shares of Class B Stock that were validly tendered and not properly
withdrawn before the expiration of the Offer.
1
<PAGE> 3
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
By: THOMAS R. RAUMAN
-----------------------------------
Name: Thomas R. Rauman
Title: Chief Financial Officer
Dated: March 7, 1996
2